MD
Rush S. Dickson Distinguished Professor of Medicine
Co-Leader, UNC Lineberger Cancer Genetics Research Program
UNC-Chapel Hill
Urologic Oncology Program
Cancer Genetics, Clinical Research
Meet William Kim
Area of Interest
Kim is a laboratory-based physician-scientist. Clinically, Kim takes care of patients with genitourinary malignancies.
The Kim Laboratory studies the genetics and cancer biology underlying the initiation and progression of bladder and kidney cancers. The Kim Lab uses in vitro methods as well as patient derived xenograft tumors and genetically engineered murine (GEM) models of cancer. Kim co-directs UNC’s Mouse Phase 1 Unit (MP1U) and is involved in the Next Gen sequencing of both human cancer genomes as the interim Director for Precision Oncology for UNC Lineberger.
Awards and Honors
- Rush S. Dickson Distinguished Professor, 2015
- Bladder Cancer Advocacy Network (BCAN) Innovation Award, 2014
- Elected member, the American Society of Clinical Investigation (ASCI), 2014
- AACR, Kure It, Grant for Kidney Cancer Research, 2012
- University Cancer Research Fund, Innovation Award, 2010
- DOD Prostate Cancer, Physician Research Training Award, 2010
- Damon Runyon, Clinical Investigator Award, 2009
- Joan’s Legacy Lung Cancer Foundation Award, 2008
- DOD Prostate Cancer New Investigator Award, 2008
- Harvard Medical School Scholars in Medicine Award, 2003
- ASCO Young Investigator Award, 2002
- White Prize, for study in Economics, Wesleyan University, 1992
- Howard Hughes Research Fellow, Wesleyan University, 1991
News and Stories
Kim, Rose highlight advances in kidney cancer research and care in JAMA
William Kim, MD, and Tracy Rose, MD, MPH, published a review highlighting new scientific insights that have led to advances in kidney cancer treatment and increased survival rates.
Scientific retreat underscores impact and promise of cancer center’s research
UNC Lineberger's annual scientific retreat brought together faculty, staff and trainees to learn about the latest research at the cancer center.
